Qiao Xue, Wang Yipeng, Yu Haining
School of Biological Engineering, Dalian University of Technology, Dalian 116024, Liaoning, China.
School of Life Sciences, Suzhou University, Suzhou 215123, Jiangsu, China.
Sheng Wu Gong Cheng Xue Bao. 2019 Aug 25;35(8):1391-1400. doi: 10.13345/j.cjb.190033.
In recent years, cancer has become a major concern in relation to human morbidity and mortality. Anticancer peptides (ACPs) are the bioactive peptide with antitumor activity and found in many organisms, including mammals, amphibians, insects, plants and microorganisms. ACPs have been suggested as promising agents for antitumor therapy due to their numerous advantages over traditional chemical agents such as low molecular masses, relatively simple structures, greater tumor selectivity, fewer adverse reactions, ease of absorption, a variety of routes of administration and low risk for inducing multi-drug resistance. Combining with the related research in our group, we summarized the mechanisms of ACPs to provide some directions for research and development of peptide-based anticancer drugs.
近年来,癌症已成为关乎人类发病率和死亡率的主要问题。抗癌肽(ACPs)是具有抗肿瘤活性的生物活性肽,存在于包括哺乳动物、两栖动物、昆虫、植物和微生物在内的许多生物体中。由于与传统化学药物相比,抗癌肽具有诸多优势,如分子量低、结构相对简单、肿瘤选择性更高、不良反应更少、易于吸收、给药途径多样以及诱导多药耐药的风险低等,因此被认为是有前景的抗肿瘤治疗药物。结合我们团队的相关研究,我们总结了抗癌肽的作用机制,为基于肽的抗癌药物的研发提供一些方向。